Correlates of Bleeding Events Among Moderate- to High-Risk Patients Undergoing Percutaneous Coronary Intervention and Treated With Eptifibatide
- 30 May 2006
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 47 (12) , 2374-2379
- https://doi.org/10.1016/j.jacc.2005.09.080
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Excess Dosing of Antiplatelet and Antithrombin Agents in the Treatment of Non–ST-Segment Elevation Acute Coronary SyndromesJAMA, 2005
- Relationship of Blood Transfusion and Clinical Outcomes in Patients With Acute Coronary SyndromesJAMA, 2004
- Outcome in Elderly Patients Undergoing Primary Coronary Intervention for Acute Myocardial InfarctionCirculation, 2004
- Antithrombotic Therapy During Percutaneous Coronary InterventionChest, 2004
- Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventionsThe American Journal of Cardiology, 2003
- Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary InterventionJAMA, 2003
- Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trialJournal of the American College of Cardiology, 2003
- Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trialThe Lancet, 2000
- Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II)The American Journal of Cardiology, 2000
- Long-term Protection From Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade With Percutaneous Coronary InterventionJAMA, 1997